• Je něco špatně v tomto záznamu ?

Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy

PR. Bauer, S. Chevret, H. Yadav, S. Mehta, P. Pickkers, RB. Bukan, J. Rello, A. van de Louw, K. Klouche, AP. Meert, I. Martin-Loeches, B. Marsh, L. Socias Crespi, G. Moreno-Gonzalez, N. Buchtele, K. Amrein, M. Balik, M. Antonelli, M. Nyunga, A....

. 2019 ; 54 (1) : . [pub] 20190725

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025766

OBJECTIVE: We wished to explore the use, diagnostic capability and outcomes of bronchoscopy added to noninvasive testing in immunocompromised patients. In this setting, an inability to identify the cause of acute hypoxaemic respiratory failure is associated with worse outcome. Every effort should be made to obtain a diagnosis, either with noninvasive testing alone or combined with bronchoscopy. However, our understanding of the risks and benefits of bronchoscopy remains uncertain. PATIENTS AND METHODS: This was a pre-planned secondary analysis of Efraim, a prospective, multinational, observational study of 1611 immunocompromised patients with acute respiratory failure admitted to the intensive care unit (ICU). We compared patients with noninvasive testing only to those who had also received bronchoscopy by bivariate analysis and after propensity score matching. RESULTS: Bronchoscopy was performed in 618 (39%) patients who were more likely to have haematological malignancy and a higher severity of illness score. Bronchoscopy alone achieved a diagnosis in 165 patients (27% adjusted diagnostic yield). Bronchoscopy resulted in a management change in 236 patients (38% therapeutic yield). Bronchoscopy was associated with worsening of respiratory status in 69 (11%) patients. Bronchoscopy was associated with higher ICU (40% versus 28%; p<0.0001) and hospital mortality (49% versus 41%; p=0.003). The overall rate of undiagnosed causes was 13%. After propensity score matching, bronchoscopy remained associated with increased risk of hospital mortality (OR 1.41, 95% CI 1.08-1.81). CONCLUSIONS: Bronchoscopy was associated with improved diagnosis and changes in management, but also increased hospital mortality. Balancing risk and benefit in individualised cases should be investigated further.

CIBERES Instituto Salud Carlos 3 and Vall d'Hebron Institut of Research Barcelona Barcelona Spain

Dept of Anesthesia Intensive Care and Pain Therapy University of Foggia Policlinico OO Riuniti Foggia Italy

Dept of Anesthesiology 1 Herlev University Hospital Herlev Denmark

Dept of Anesthesiology and Intensive Care Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Dept of Anesthesiology Herlev University Hospital UCPH Herlev Denmark

Dept of Anesthesiology Intensive Care and Emergency Medicine Fondazione Policlinico Universitario A Gemelli IRCCS Università Cattolica del Sacro Cuore Rome Italy

Dept of Clinical Pharmacology Medical University of Vienna Vienna Austria

Dept of Critical Care Hospital Son Llatzer Palma de Mallorca Spain

Dept of Critical Care King's College Hospital NHS Foundation Trust London UK

Dept of Critical Care Mater Misericordiae Dublin Ireland

Dept of Critical Care University Hospital Lyon Sud Pierre Benite France

Dept of Emergencies and Critical Care Oslo University Hospital Rikshospitalet Oslo Norway

Dept of Intensive Care Amsterdam UMC VU Medical Center Amsterdam The Netherlands

Dept of Intensive Care Hospital Universitari de Bellvitge Barcelona Spain

Dept of Intensive Care Maastricht University Medical Centre Maastricht The Netherlands

Dept of Intensive Care Medicine Lapeyronie University Hospital Montpellier France

Dept of Intensive Care Medicine Radboud University Medical Center Nijmegen The Netherlands

Dept of Intensive Care Medicine St Olav's University Hospital Trondheim Norway

Dept of Intensive Care Medicine Universidad de Barcelona IDIBAPS Barcelona Spain Dept of Clinical Medicine Trinity College Wellcome Trust HRB Clinical Research Facility St James Hospital Dublin Ireland

Dept of Intensive Care Tampere University Hospital Tampere Finland

Dept of Internal Medicine Division of Endocrinology and Diabetology Medical University of Graz and Thyroid Endocrinology Osteoporosis Institute Dobnig Graz Austria

Dept of Medicine and Interdepartmental Division of Critical Care Medicine Sinai Health System University of Toronto Toronto ON Canada

Division of Pulmonary and Critical Care Medicine Mayo Clinic Rochester MN USA

Division of Pulmonary and Critical Care Penn State University College of Medicine Hershey PA USA

ECSTRA Team Biostatistics and Clinical Epidemiology UMR 1153 INSERM Paris Diderot Sorbonne University and Service de Biostatistique et Information Médicale AP HP Hôpital Saint Louis Paris France

Medical ICU 1st Dept of Internal Medicine Teaching Hospital Faculty of Medicine and Biomedical Center in Pilsen Charles University Pilsen Czech Republic

Medical Intensive Care Unit AP HP Hôpital Saint Louis Famirea Study Group ECSTRA Team and Clinical Epidemiology UMR 1153 Center of Epidemiology and Biostatistics Sorbonne Paris Cité CRESS INSERM Paris Diderot Sorbonne University Paris France

Medical Intensive Care Unit CHG Victor Provo Roubaix France

Réanimation Médicale CHU de Caen Caen France

Réanimation Polyvalente et Département d'Anesthésie et de Réanimation Institut Paoli Calmettes Marseille France

Service de Médecine Interne Unité de Soins Intensifs et Urgences Oncologiques Université de Libre de Bruxelles Institut Jules Bordet Brussels Belgium

Service de Pneumologie et Réanimation CHU Pitié Salpétrière Paris France

Terapia Intensiva Hospital Maciel Montevideo Uruguay

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025766
003      
CZ-PrNML
005      
20201222154101.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1183/13993003.02442-2018 $2 doi
035    __
$a (PubMed)31109985
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Bauer, Philippe R $u Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA Bauer.Philippe@mayo.edu.
245    10
$a Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy / $c PR. Bauer, S. Chevret, H. Yadav, S. Mehta, P. Pickkers, RB. Bukan, J. Rello, A. van de Louw, K. Klouche, AP. Meert, I. Martin-Loeches, B. Marsh, L. Socias Crespi, G. Moreno-Gonzalez, N. Buchtele, K. Amrein, M. Balik, M. Antonelli, M. Nyunga, A. Barratt-Due, DCJJ. Bergmans, AME. Spoelstra-de Man, A. Kuitunen, F. Wallet, A. Seguin, V. Metaxa, V. Lemiale, G. Burghi, A. Demoule, T. Karvunidis, A. Cotoia, P. Klepstad, AM. Møller, D. Mokart, E. Azoulay, Efraim investigators and the Nine-I study group,
520    9_
$a OBJECTIVE: We wished to explore the use, diagnostic capability and outcomes of bronchoscopy added to noninvasive testing in immunocompromised patients. In this setting, an inability to identify the cause of acute hypoxaemic respiratory failure is associated with worse outcome. Every effort should be made to obtain a diagnosis, either with noninvasive testing alone or combined with bronchoscopy. However, our understanding of the risks and benefits of bronchoscopy remains uncertain. PATIENTS AND METHODS: This was a pre-planned secondary analysis of Efraim, a prospective, multinational, observational study of 1611 immunocompromised patients with acute respiratory failure admitted to the intensive care unit (ICU). We compared patients with noninvasive testing only to those who had also received bronchoscopy by bivariate analysis and after propensity score matching. RESULTS: Bronchoscopy was performed in 618 (39%) patients who were more likely to have haematological malignancy and a higher severity of illness score. Bronchoscopy alone achieved a diagnosis in 165 patients (27% adjusted diagnostic yield). Bronchoscopy resulted in a management change in 236 patients (38% therapeutic yield). Bronchoscopy was associated with worsening of respiratory status in 69 (11%) patients. Bronchoscopy was associated with higher ICU (40% versus 28%; p<0.0001) and hospital mortality (49% versus 41%; p=0.003). The overall rate of undiagnosed causes was 13%. After propensity score matching, bronchoscopy remained associated with increased risk of hospital mortality (OR 1.41, 95% CI 1.08-1.81). CONCLUSIONS: Bronchoscopy was associated with improved diagnosis and changes in management, but also increased hospital mortality. Balancing risk and benefit in individualised cases should be investigated further.
650    _2
$a senioři $7 D000368
650    _2
$a bronchoskopie $x škodlivé účinky $x přístrojové vybavení $7 D001999
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hematologické nádory $x diagnostické zobrazování $7 D019337
650    _2
$a mortalita v nemocnicích $7 D017052
650    _2
$a lidé $7 D006801
650    12
$a hostitel s imunodeficiencí $7 D016867
650    _2
$a jednotky intenzivní péče $x statistika a číselné údaje $7 D007362
650    _2
$a logistické modely $7 D016015
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neinvazivní ventilace $x metody $7 D063087
650    _2
$a prospektivní studie $7 D011446
650    _2
$a respirační insuficience $x diagnóza $x patofyziologie $7 D012131
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Chevret, Sylvie $u ECSTRA Team, Biostatistics and Clinical Epidemiology, UMR 1153, INSERM, Paris Diderot Sorbonne University and Service de Biostatistique et Information Médicale, AP-HP, Hôpital Saint-Louis, Paris, France.
700    1_
$a Yadav, Hemang $u Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
700    1_
$a Mehta, Sangeeta $u Dept of Medicine and Interdepartmental Division of Critical Care Medicine, Sinai Health System, University of Toronto, Toronto, ON, Canada.
700    1_
$a Pickkers, Peter $u Dept of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
700    1_
$a Bukan, Ramin B $u Dept of Anesthesiology I, Herlev University Hospital, Herlev, Denmark.
700    1_
$a Rello, Jordi $u CIBERES, Instituto Salud Carlos III and Vall d'Hebron Institut of Research Barcelona, Barcelona, Spain.
700    1_
$a van de Louw, Andry $u Division of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, PA, USA.
700    1_
$a Klouche, Kada $u Dept of Intensive Care Medicine, Lapeyronie University Hospital, Montpellier, France.
700    1_
$a Meert, Anne-Pascale $u Service de Médecine Interne, Unité de Soins Intensifs et Urgences Oncologiques, Université de Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium.
700    1_
$a Martin-Loeches, Ignacio $u Dept of Intensive Care Medicine, Universidad de Barcelona IDIBAPS, Barcelona, Spain. Dept of Clinical Medicine, Trinity College, Wellcome Trust-HRB Clinical Research Facility, St James Hospital, Dublin, Ireland.
700    1_
$a Marsh, Brian $u Dept of Critical Care, Mater Misericordiae, Dublin, Ireland.
700    1_
$a Socias Crespi, Lorenzo $u Dept of Critical Care, Hospital Son Llatzer, Palma de Mallorca, Spain.
700    1_
$a Moreno-Gonzalez, Gabriel $u Dept of Intensive Care, Hospital Universitari de Bellvitge, Barcelona, Spain.
700    1_
$a Buchtele, Nina $u Dept of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
700    1_
$a Amrein, Karin $u Dept of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz and Thyroid Endocrinology Osteoporosis Institute Dobnig, Graz, Austria.
700    1_
$a Balik, Martin $u Dept of Anesthesiology and Intensive Care Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Antonelli, Massimo $u Dept of Anesthesiology Intensive Care and Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy.
700    1_
$a Nyunga, Martine $u Medical Intensive Care Unit, CHG Victor Provo, Roubaix, France.
700    1_
$a Barratt-Due, Andreas $u Dept of Emergencies and Critical Care, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
700    1_
$a Bergmans, Dennis C J J $u Dept of Intensive Care, Maastricht University Medical Centre, Maastricht, The Netherlands.
700    1_
$a Spoelstra-de Man, Angélique M E $u Dept of Intensive Care, Amsterdam UMC, VU Medical Center, Amsterdam, The Netherlands.
700    1_
$a Kuitunen, Anne $u Dept of Intensive Care, Tampere University Hospital, Tampere, Finland.
700    1_
$a Wallet, Florent $u Dept of Critical Care, University Hospital Lyon Sud, Pierre Benite, France.
700    1_
$a Seguin, Amelie $u Réanimation Médicale, CHU de Caen, Caen, France.
700    1_
$a Metaxa, Victoria $u Dept of Critical Care, King's College Hospital NHS Foundation Trust, London, UK.
700    1_
$a Lemiale, Virginie $u Medical Intensive Care Unit, AP-HP, Hôpital Saint-Louis, Famirea Study Group, ECSTRA Team, and Clinical Epidemiology, UMR 1153, Center of Epidemiology and Biostatistics, Sorbonne Paris Cité, CRESS, INSERM, Paris Diderot Sorbonne University, Paris, France.
700    1_
$a Burghi, Gaston $u Terapia Intensiva, Hospital Maciel, Montevideo, Uruguay.
700    1_
$a Demoule, Alexandre $u Service de Pneumologie et Réanimation, CHU Pitié-Salpétrière, Paris, France.
700    1_
$a Karvunidis, Thomas $u Medical ICU, First Dept of Internal Medicine, Teaching Hospital, Faculty of Medicine and Biomedical Center in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Cotoia, Antonella $u Dept of Anesthesia, Intensive Care, and Pain Therapy, University of Foggia, Policlinico "OO Riuniti", Foggia, Italy.
700    1_
$a Klepstad, Pål $u Dept of Intensive Care Medicine, St Olav's University Hospital, Trondheim, Norway.
700    1_
$a Møller, Ann M $u Dept of Anesthesiology, Herlev University Hospital, UCPH, Herlev, Denmark.
700    1_
$a Mokart, Djamel $u Réanimation Polyvalente et Département d'Anesthésie et de Réanimation, Institut Paoli-Calmettes, Marseille, France.
700    1_
$a Azoulay, Elie $u Medical Intensive Care Unit, AP-HP, Hôpital Saint-Louis, Famirea Study Group, ECSTRA Team, and Clinical Epidemiology, UMR 1153, Center of Epidemiology and Biostatistics, Sorbonne Paris Cité, CRESS, INSERM, Paris Diderot Sorbonne University, Paris, France.
710    2_
$a Efraim investigators and the Nine-I study group
773    0_
$w MED00001660 $t The European respiratory journal $x 1399-3003 $g Roč. 54, č. 1 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31109985 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222154056 $b ABA008
999    __
$a ok $b bmc $g 1599911 $s 1116452
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 54 $c 1 $e 20190725 $i 1399-3003 $m The European respiratory journal $n Eur Respir J $x MED00001660
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace